Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Cannabidiol

EU orphan designation number: EU/3/17/1855   
Active ingredient: Cannabidiol
Indication: Treatment of Lennox-Gastaut syndrome
Sponsor: GW Pharma (International) B.V
Databankweg 26, Amersfoort, Utrecht, 3821 AL, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/03/2017 Orphan designation EMA/OD/275/16 (2017)1983 of 20/03/2017
12/04/2019 Transfer of orphan designation EMA/OD/0000004607 (2019)2926 of 10/04/2019